NCT05952609 is a NA clinical trial of Surefil One in Secondary Caries, sponsored by Mansoura University.

Who is sponsoring NCT05952609?

NCT05952609 is sponsored by Mansoura University.

What drugs are being tested in NCT05952609?

Interventions in NCT05952609: Surefil One, Cention N, Bulkfil resin composite.

What condition does NCT05952609 study?

NCT05952609 studies Secondary Caries.

Is NCT05952609 still recruiting?

NCT05952609 is currently completed. Last updated 19 July 2023.

Last reviewed 2023-07-19 · How we verify

NCT05952609

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A 2-year Clinical Performance of Two Different Ion-releasing Bulk-fill Restorative Materials Posterior Cavities

Completed NA Last updated 19 July 2023

What this trial tests

NA trial testing Surefil One in Secondary Caries in 32 participants. Completed in 15 May 2023.

Timeline

10 February 2021

Primary endpoint
15 April 2023

15 May 2023

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	treatment
Enrollment	32
Start date	10 February 2021
Primary completion	15 April 2023
Estimated completion	15 May 2023
Sites	1 location across Egypt

Drugs / interventions tested

Surefil One
Cention N
Bulkfil resin composite

Conditions studied

Secondary Caries — all drugs for Secondary Caries →

Sponsor

Mansoura University

Who can join

Adults 18 to 60, any sex, with Secondary Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate and compare the clinical performance of 2 ion-releasing bulk-fill restorative materials in comparison with a bulk-fill resin composite restoration in posterior cavities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Secondary Caries

Currently open trials in the same condition.

NCT06164418 — Comparative Evaluation of Class V Restorations · NA · active not recruiting
NCT03108586 — Caries Cognition and Identification in Adults · NA · active not recruiting

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05952609 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 19 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05952609.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing